Cargando…

Deaths related to differentiated thyroid cancer: a rare but real event

OBJECTIVE: The present study describes the clinical and tumor characteristics of patients that died from differentiated thyroid cancer and reports on the cause and circumstances of death in these cases. SUBJECTS AND METHODS: Retrospective analysis of all the differentiated thyroid cancer (DTC) relat...

Descripción completa

Detalles Bibliográficos
Autores principales: Leite, Ana Kober N., Cavalheiro, Beatriz G., Kulcsar, Marco Aurélio, Hoff, Ana de Oliveira, Brandão, Lenine G., Cernea, Claudio Roberto, Matos, Leandro L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Endocrinologia e Metabologia 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118796/
https://www.ncbi.nlm.nih.gov/pubmed/28699989
http://dx.doi.org/10.1590/2359-3997000000261
_version_ 1785028876988055552
author Leite, Ana Kober N.
Cavalheiro, Beatriz G.
Kulcsar, Marco Aurélio
Hoff, Ana de Oliveira
Brandão, Lenine G.
Cernea, Claudio Roberto
Matos, Leandro L.
author_facet Leite, Ana Kober N.
Cavalheiro, Beatriz G.
Kulcsar, Marco Aurélio
Hoff, Ana de Oliveira
Brandão, Lenine G.
Cernea, Claudio Roberto
Matos, Leandro L.
author_sort Leite, Ana Kober N.
collection PubMed
description OBJECTIVE: The present study describes the clinical and tumor characteristics of patients that died from differentiated thyroid cancer and reports on the cause and circumstances of death in these cases. SUBJECTS AND METHODS: Retrospective analysis of all the differentiated thyroid cancer (DTC) related deaths at a single institution over a 5-year period, with a total of 33 patients. RESULTS: Most of the patients were female (63.6%), with a mean age at diagnosis of 58.2 years. The most common histologic type was papillary (66.7%) and 30.3% were follicular. The distribution according to the TNM classification was: 15.4% of T1; 7.7% T2; 38.4% T3; 19.2% of T4a and 19.2% of T4b. Forty-four percent of cases were N0; 20% N1a and 36.6% of N1b. Twelve patients were considered non-responsive to radioiodine. Only one of the patients did not have distant metastases. The most common metastatic site was the lung in 69.7%. The majority of deaths were due to pulmonary complications related to lung metastases (17 patients, 51.5%), followed by post-operative complications in 5 cases, neurological disease progression in 3 cases, local invasion and airway obstruction in one patient. Median survival between diagnosis and death was reached in 49 months while between disease progression and death it was at 22 months. CONCLUSION: Mortality from DTC is extremely rare but persists, and the main causes of death derive from distant metastasis, especially respiratory failure due to lung metastasis. Once disease progression is established, median survival was only 22 months.
format Online
Article
Text
id pubmed-10118796
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Sociedade Brasileira de Endocrinologia e Metabologia
record_format MEDLINE/PubMed
spelling pubmed-101187962023-04-21 Deaths related to differentiated thyroid cancer: a rare but real event Leite, Ana Kober N. Cavalheiro, Beatriz G. Kulcsar, Marco Aurélio Hoff, Ana de Oliveira Brandão, Lenine G. Cernea, Claudio Roberto Matos, Leandro L. Arch Endocrinol Metab Original Article OBJECTIVE: The present study describes the clinical and tumor characteristics of patients that died from differentiated thyroid cancer and reports on the cause and circumstances of death in these cases. SUBJECTS AND METHODS: Retrospective analysis of all the differentiated thyroid cancer (DTC) related deaths at a single institution over a 5-year period, with a total of 33 patients. RESULTS: Most of the patients were female (63.6%), with a mean age at diagnosis of 58.2 years. The most common histologic type was papillary (66.7%) and 30.3% were follicular. The distribution according to the TNM classification was: 15.4% of T1; 7.7% T2; 38.4% T3; 19.2% of T4a and 19.2% of T4b. Forty-four percent of cases were N0; 20% N1a and 36.6% of N1b. Twelve patients were considered non-responsive to radioiodine. Only one of the patients did not have distant metastases. The most common metastatic site was the lung in 69.7%. The majority of deaths were due to pulmonary complications related to lung metastases (17 patients, 51.5%), followed by post-operative complications in 5 cases, neurological disease progression in 3 cases, local invasion and airway obstruction in one patient. Median survival between diagnosis and death was reached in 49 months while between disease progression and death it was at 22 months. CONCLUSION: Mortality from DTC is extremely rare but persists, and the main causes of death derive from distant metastasis, especially respiratory failure due to lung metastasis. Once disease progression is established, median survival was only 22 months. Sociedade Brasileira de Endocrinologia e Metabologia 2017-03-20 /pmc/articles/PMC10118796/ /pubmed/28699989 http://dx.doi.org/10.1590/2359-3997000000261 Text en https://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Leite, Ana Kober N.
Cavalheiro, Beatriz G.
Kulcsar, Marco Aurélio
Hoff, Ana de Oliveira
Brandão, Lenine G.
Cernea, Claudio Roberto
Matos, Leandro L.
Deaths related to differentiated thyroid cancer: a rare but real event
title Deaths related to differentiated thyroid cancer: a rare but real event
title_full Deaths related to differentiated thyroid cancer: a rare but real event
title_fullStr Deaths related to differentiated thyroid cancer: a rare but real event
title_full_unstemmed Deaths related to differentiated thyroid cancer: a rare but real event
title_short Deaths related to differentiated thyroid cancer: a rare but real event
title_sort deaths related to differentiated thyroid cancer: a rare but real event
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118796/
https://www.ncbi.nlm.nih.gov/pubmed/28699989
http://dx.doi.org/10.1590/2359-3997000000261
work_keys_str_mv AT leiteanakobern deathsrelatedtodifferentiatedthyroidcancerararebutrealevent
AT cavalheirobeatrizg deathsrelatedtodifferentiatedthyroidcancerararebutrealevent
AT kulcsarmarcoaurelio deathsrelatedtodifferentiatedthyroidcancerararebutrealevent
AT hoffanadeoliveira deathsrelatedtodifferentiatedthyroidcancerararebutrealevent
AT brandaolenineg deathsrelatedtodifferentiatedthyroidcancerararebutrealevent
AT cerneaclaudioroberto deathsrelatedtodifferentiatedthyroidcancerararebutrealevent
AT matosleandrol deathsrelatedtodifferentiatedthyroidcancerararebutrealevent